{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:24:38Z","timestamp":1787142278224,"version":"build-2736575974"},"reference-count":79,"publisher":"American Chemical Society (ACS)","issue":"8","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Shiga toxins (Stx) are key virulence factors of Shiga toxin-producing Escherichia coli (STEC), which are responsible for severe foodborne infections that can progress to hemolytic-uremic syndrome (HUS). Currently, no specific antitoxin therapies are available. In this study, we devised a glycoengineering strategy utilizing Functional-Spacer-Lipid (FSL) conjugates to create small extracellular vesicles (sEVs)-based decoy receptors for Shiga toxin type 1 (Stx1). sEVs isolated from human Caco-2 and HEK293T cells were functionalized with Gb3 trisaccharide (Gal\u03b11\u21924Gal\u03b21\u21924Glc)-containing FSL conjugates, yielding Gb3-decorated vesicles displaying the Gal\u03b11\u21924Gal epitope. Characterization of FSL-modified sEVs confirmed that FSL incorporation did not adversely affect sEV morphology, size distribution, or surface charge. Western blotting and bead-assisted flow cytometry verified the presence of exosomal markers (CD9 and CD63) and the Gb3 epitope on modified vesicles. Gb3-tagged sEVs from both cell types exhibited high specificity in binding Stx1B, while control vesicles carrying Galili epitope (Gal\u03b11\u21923Gal\u03b21\u21924GlcNAc), lacking Stx1B binding, demonstrated negligible binding. Gb3-expressing Caco-2 cell-based assays revealed that Gb3-decorated sEVs markedly reduced Stx1B binding to Caco-2 cells, indicating effective competition with cellular receptors. Furthermore, glycoengineered sEVs did not impair Caco-2 cell viability at concentrations sufficient for Stx1B sequestration. These findings establish FSL-mediated glycoengineering as a rapid and versatile approach for generating sEV-based decoy receptors that effectively bind Stx1B. Gb3-containing human sEVs may serve as an agent for neutralizing Stx1B and potentially other glycan-binding toxins, supporting the development of promising next-generation antitoxin therapeutics.<\/jats:p>","DOI":"10.1021\/acs.bioconjchem.6c00243","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T03:11:24Z","timestamp":1785985884000},"page":"1665-1677","source":"Crossref","is-referenced-by-count":0,"title":["Surface Functionalization of Small Extracellular Vesicles\nDerived from Caco-2 and HEK293T Cells in the Neutralization\nof Shiga Toxin 1 Subunit B"],"prefix":"10.1021","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1879-2205","authenticated-orcid":true,"given":"Krzysztof","family":"Mikolajczyk","sequence":"first","affiliation":[{"name":"Polish Academy of Sciences , , 12 Rudolfa Weigla St , ,","place":["Wroclaw, Poland, 53-114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bereznicka","sequence":"additional","affiliation":[{"name":"Polish Academy of Sciences , , 12 Rudolfa Weigla St , ,","place":["Wroclaw, Poland, 53-114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Czernek","sequence":"additional","affiliation":[{"name":"Polish Academy of Sciences , , ,","place":["Lodz, Poland, 90-363"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2996-5714","authenticated-orcid":true,"given":"Alice","family":"Gualerzi","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi Ets , , ,","place":["Milano, Italy, 20148"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Forleo","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi Ets , , ,","place":["Milano, Italy, 20148"]},{"name":"University of Milan , , ,","place":["Milan, Italy, 20122"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Bedoni","sequence":"additional","affiliation":[{"name":"IRCCS Fondazione Don Carlo Gnocchi Ets , , ,","place":["Milano, Italy, 20148"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Lodej","sequence":"additional","affiliation":[{"name":"Polish Academy of Sciences , , ,","place":["Wroclaw, Poland, 53-114"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Migdal","sequence":"additional","affiliation":[{"name":"Polish Academy of Sciences , , ,","place":["Wroclaw, Poland, 53-114"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"2026081907205994400_cit1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fcimb.2020.00169","article-title":"Treatment Strategies\nfor Infections With Shiga Toxin-Producing Escherichia Coli","volume":"10","author":"Mu\u0308hlen","year":"2020","journal-title":"Front. Cell.\nInfect. Microbiol."},{"issue":"2","key":"2026081907205994400_cit2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrmicro2279","article-title":"Shiga Toxins\u2013from\nCell Biology to Biomedical\nApplications","volume":"8","author":"Johannes","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"2026081907205994400_cit3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s11658-024-00658-7","article-title":"Human Gb3\/CD77 Synthase: A Glycosyltransferase\nat the Crossroads of Immunohematology, Toxicology, and Cancer Research","volume":"29","author":"Szymczak-Kulus","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"2026081907205994400_cit4","doi-asserted-by":"publisher","first-page":"100299","DOI":"10.1016\/j.jbc.2021.100299","article-title":"Human Gb3\/CD77 Synthase Produces P1 Glycotope-Capped\nN-Glycans, Which Mediate Shiga Toxin 1 but Not Shiga Toxin 2 Cell\nEntry","volume":"296","author":"Szymczak-Kulus","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"28","key":"2026081907205994400_cit5","doi-asserted-by":"publisher","first-page":"9490","DOI":"10.1074\/jbc.RA120.013926","article-title":"Blood Group\nP1 Antigen-Bearing Glycoproteins Are Functional but Less Efficient\nReceptors of Shiga Toxin than Conventional Glycolipid-Based Receptors","volume":"295","author":"Morimoto","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"6","key":"2026081907205994400_cit6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/fpd.2013.1704","article-title":"Global Incidence\nof Human Shiga Toxin-Producing Escherichia Coli Infections and Deaths: A Systematic Review and Knowledge Synthesis","volume":"11","author":"Majowicz","year":"2014","journal-title":"Foodborne Pathog. Dis."},{"key":"2026081907205994400_cit7","unstructured":"European Centre for Disease Prevention and Control.\n          \n          https:\/\/www.ecdc.europa.eu\/en\/publications-data\/stec-infection-cases-annual-epidemiological-report-2023 (Accessed 2025\u201308\u201304)."},{"key":"2026081907205994400_cit8","doi-asserted-by":"publisher","first-page":"111253","DOI":"10.1016\/j.cellsig.2024.111253","article-title":"One Problem, Multiple Potential Targets:\nWhere Are We Now in the Development of Small Molecule Inhibitors against\nShiga Toxin?","volume":"121","author":"Tucker","year":"2024","journal-title":"Cell. Signalling"},{"issue":"6770","key":"2026081907205994400_cit9","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/35001095","article-title":"Shiga-like\nToxins Are Neutralized by Tailored Multivalent Carbohydrate Ligands","volume":"403","author":"Kitov","year":"2000","journal-title":"Nature"},{"issue":"2","key":"2026081907205994400_cit10","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1074\/jbc.M113.518886","article-title":"The Crystal Structure of Shiga Toxin\nType 2 with Bound Disaccharide Guides the Design of a Heterobifunctional\nToxin Inhibitor","volume":"289","author":"Jacobson","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"2026081907205994400_cit11","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/infdis\/171.4.1042","article-title":"A Phase I Study of Chemically Synthesized\nVerotoxin (Shiga-like Toxin) Pk-Trisaccharide Receptors Attached to\nChromosorb for Preventing Hemolytic-Uremic Syndrome","volume":"171","author":"Armstrong","year":"1995","journal-title":"J. Infect. Dis."},{"issue":"10","key":"2026081907205994400_cit12","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1001\/jama.290.10.1337","article-title":"Investigators of the HUS-SYNSORB\nPk Multicenter Clinical\nTrial. Effect of an Oral Shiga Toxin-Binding Agent on Diarrhea-Associated\nHemolytic Uremic Syndrome in Children: A Randomized Controlled Trial","volume":"290","author":"Trachtman","year":"2003","journal-title":"JAMA"},{"issue":"6","key":"2026081907205994400_cit13","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1093\/infdis\/164.6.1160","article-title":"Investigation of Shiga-like\nToxin\nBinding to Chemically Synthesized Oligosaccharide Sequences","volume":"164","author":"Armstrong","year":"1991","journal-title":"J. Infect. Dis."},{"issue":"11","key":"2026081907205994400_cit14","doi-asserted-by":"publisher","first-page":"7669","DOI":"10.1073\/pnas.112058999","article-title":"A Therapeutic Agent\nwith Oriented Carbohydrates for Treatment of Infections by Shiga Toxin-Producing Escherichia Coli O157: H7","volume":"99","author":"Nishikawa","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"2026081907205994400_cit15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jviromet.2011.06.005","article-title":"Fluorescein and\nRadiolabeled Function-Spacer-Lipid Constructs Allow for Simple in\nVitro and in Vivo Bioimaging of Enveloped Virions","volume":"176","author":"Hadac","year":"2011","journal-title":"J. Virol. Methods"},{"issue":"8","key":"2026081907205994400_cit16","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1111\/j.1537-2995.2010.03034.x","article-title":"Modeling Transfusion\nReactions and\nPredicting in Vivo Cell Survival with Kodecytes","volume":"51","author":"Oliver","year":"2011","journal-title":"Transfusion"},{"issue":"54","key":"2026081907205994400_cit17","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.3791\/3289","article-title":"FSL Constructs:\nA Simple Method for Modifying Cell\/Virion Surfaces with a Range of\nBiological Markers Without Affecting Their Viability","author":"Blake","year":"2011","journal-title":"J. Vis. Exp."},{"issue":"5","key":"2026081907205994400_cit18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s10719-010-9297-y","article-title":"A Synthetic\nGlobotriaosylceramide Analogue Inhibits HIV-1 Infection in Vitro by\nTwo Mechanisms","volume":"27","author":"Harrison","year":"2010","journal-title":"Glycoconj. J."},{"issue":"3","key":"2026081907205994400_cit19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/01.aids.0000206499.78664.58","article-title":"A Novel Soluble Mimic of the Glycolipid,\nGlobotriaosyl Ceramide Inhibits HIV Infection","volume":"20","author":"Lund","year":"2006","journal-title":"AIDS"},{"issue":"6","key":"2026081907205994400_cit20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/aps.2017.12","article-title":"Engineering Exosomes as Refined Biological Nanoplatforms for Drug\nDelivery","volume":"38","author":"Luan","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"2026081907205994400_cit21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1039\/C9BM01232J","article-title":"Nanogel Hybrid\nAssembly for Exosome\nIntracellular Delivery: Effects on Endocytosis and Fusion by Exosome\nSurface Polymer Engineering","volume":"8","author":"Sawada","year":"2020","journal-title":"Biomater. Sci."},{"key":"2026081907205994400_cit22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13287-022-02806-2","article-title":"Engineering\nStrategies for Customizing Extracellular Vesicle Uptake in a Therapeutic\nContext","volume":"13","author":"Esmaeili","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"9","key":"2026081907205994400_cit23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads5249","article-title":"Leveraging Nature\u2019s Nanocarriers: Translating\nInsights from Extracellular Vesicles to Biomimetic Synthetic Vesicles\nfor Biomedical Applications","volume":"11","author":"Chen","year":"2025","journal-title":"Sci. Adv."},{"key":"2026081907205994400_cit24","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.addr.2021.03.020","article-title":"Approaches\nto Surface Engineering\nof Extracellular Vesicles","volume":"173","author":"Richter","year":"2021","journal-title":"Adv. Drug Delivery\nRev."},{"key":"2026081907205994400_cit25","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.jconrel.2021.08.037","article-title":"Engineered Extracellular\nVesicles as Brain Therapeutics","volume":"338","author":"Lino","year":"2021","journal-title":"J. Controlled\nRelease"},{"issue":"14","key":"2026081907205994400_cit26","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202005709","article-title":"Engineered Extracellular Vesicles for Cancer Therapy","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv. Mater."},{"key":"2026081907205994400_cit27","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1186\/s12967-025-07077-y","article-title":"Extracellular\nVesicles for Targeted Drug Delivery: Advances in Surface\nModification Strategies and Therapeutic Applications","volume":"23","author":"Hu","year":"2025","journal-title":"J. Transl. Med."},{"key":"2026081907205994400_cit28","doi-asserted-by":"publisher","first-page":"113816","DOI":"10.1016\/j.addr.2021.05.026","article-title":"Role of\nExtracellular Vesicles in Liver Diseases and Their Therapeutic Potential","volume":"175","author":"Kostallari","year":"2021","journal-title":"Adv. Drug Delivery Rev."},{"key":"2026081907205994400_cit29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fbioe.2025.1671963","article-title":"Clinical Applications\nof Extracellular Vesicles: Recent Advances and Emerging Trends","volume":"13","author":"Zou","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"8","key":"2026081907205994400_cit30","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1002\/sctm.17-0055","article-title":"Concise Review: Developing Best-Practice\nModels for the Therapeutic Use of Extracellular Vesicles","volume":"6","author":"Reiner","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"2026081907205994400_cit31","doi-asserted-by":"publisher","first-page":"150975","DOI":"10.1016\/j.bbrc.2024.150975","article-title":"Gb3 Trisaccharide-Bearing\nExosomes as a Novel Neutralizer for Shiga Toxin Type 1","volume":"739","author":"Miko\u0142ajczyk","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"2026081907205994400_cit32","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70004","article-title":"Bacterial Extracellular Vesicles as Intranasal Postbiotics:\nDetailed Characterization and Interaction with Airway Cells","volume":"13","author":"Razim","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"2026081907205994400_cit33","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","article-title":"Minimal Information for Studies of\nExtracellular Vesicles (MISEV2023): From Basic to Advanced Approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"10","key":"2026081907205994400_cit34","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/v12101117","article-title":"Electrostatic Surface Properties\nof Blood and Semen Extracellular Vesicles: Implications of Sialylation\nand HIV-Induced Changes on EV Internalization","volume":"12","author":"Kaddour","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"2026081907205994400_cit35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s42003-023-04911-1","article-title":"Lack of Involvement\nof CD63 and CD9 Tetraspanins in the Extracellular Vesicle Content\nDelivery Process","volume":"6","author":"Tognoli","year":"2023","journal-title":"Commun. Biol."},{"issue":"1","key":"2026081907205994400_cit36","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1038\/s41467-021-24384-2","article-title":"Specificities\nof Exosome versus Small Ectosome Secretion Revealed by Live Intracellular\nTracking of CD63 and CD9","volume":"12","author":"Mathieu","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"2026081907205994400_cit37","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1248\/bpb.b16-00891","article-title":"Characterization\nof Membrane Integrity and Morphological\nStability of Human Salivary Exosomes","volume":"40","author":"Kumeda","year":"2017","journal-title":"Biol.\nPharm. Bull."},{"key":"2026081907205994400_cit38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-12-394274-6.00003-0","article-title":"Ceramide Glycosylation Catalyzed\nby Glucosylceramide Synthase and Cancer Drug Resistance","volume":"117","author":"Liu","year":"2013","journal-title":"Adv. Cancer Res."},{"issue":"7","key":"2026081907205994400_cit39","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/jcp.24304","article-title":"Dynamics of Exosome\nInternalization and Trafficking","volume":"228","author":"Tian","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"2026081907205994400_cit40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3402\/jev.v3.24641","article-title":"Routes and Mechanisms of Extracellular\nVesicle Uptake","volume":"3","author":"Mulcahy","year":"2014","journal-title":"J. Extracell. Vesicles"},{"issue":"12","key":"2026081907205994400_cit41","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1021\/acsabm.3c00919","article-title":"Gb3-Coated Bovine Milk Exosomes as a Practical Neutralizer\nfor Shiga Toxin","volume":"6","author":"Lu","year":"2023","journal-title":"ACS Appl. Bio Mater."},{"issue":"2","key":"2026081907205994400_cit42","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.jconrel.2011.12.034","article-title":"Altering the Immune Response with Lipid-Based Nanoparticles","volume":"161","author":"Landesman-Milo","year":"2012","journal-title":"J. Controlled Release"},{"issue":"13","key":"2026081907205994400_cit43","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/j.vaccine.2012.01.070","article-title":"Design Considerations\nfor Liposomal\nVaccines: Influence of Formulation Parameters on Antibody and Cell-Mediated\nImmune Responses to Liposome Associated Antigens","volume":"30","author":"Watson","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"2026081907205994400_cit44","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity\nof Lipid Nanoparticles and Its Impact on the Efficacy of mRNA Vaccines\nand Therapeutics","volume":"55","author":"Lee","year":"2023","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"2026081907205994400_cit45","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular Vesicles as a Next-Generation\nDrug Delivery Platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"10","key":"2026081907205994400_cit46","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1021\/bc500291r","article-title":"Surface\nFunctionalization of Exosomes Using Click Chemistry","volume":"25","author":"Smyth","year":"2014","journal-title":"Bioconjugate Chem."},{"issue":"2\u20133","key":"2026081907205994400_cit47","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/0014-5793(96)00452-8","article-title":"Insertion of Poly(Ethylene\nGlycol) Derivatized Phospholipid\ninto Pre-Formed Liposomes Results in Prolonged in Vivo Circulation\nTime","volume":"386","author":"Uster","year":"1996","journal-title":"FEBS Lett."},{"issue":"1","key":"2026081907205994400_cit48","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbamem.2005.12.010","article-title":"Tresylated\nPEG-Sterols for Coupling\nof Proteins to Preformed Plain or PEGylated Liposomes","volume":"1758","author":"Steenpa\u00df","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"2026081907205994400_cit49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0005-2736(94)90004-3","article-title":"Factors Influencing\nthe Retention and Chemical Stability of Poly(Ethylene Glycol)-Lipid\nConjugates Incorporated into Large Unilamellar Vesicles","volume":"1195","author":"Parr","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"2026081907205994400_cit50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nano.2017.09.011","article-title":"Engineering\nMacrophage-Derived Exosomes for Targeted Paclitaxel Delivery to Pulmonary\nMetastases: In Vitro and in Vivo Evaluations","volume":"14","author":"Kim","year":"2018","journal-title":"Nanomedicine"},{"issue":"5","key":"2026081907205994400_cit51","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/j.1537-2995.2007.01204.x","article-title":"Synthetic\nGlycolipid Modification of Red Blood Cell Membranes","volume":"47","author":"Frame","year":"2007","journal-title":"Transfusion"},{"issue":"6","key":"2026081907205994400_cit52","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/MOH.0b013e328331257e","article-title":"Modification\nof Red Blood Cells for Laboratory Quality Control Use","volume":"16","author":"Henry","year":"2009","journal-title":"Current Opinion Hematology"},{"key":"2026081907205994400_cit53","doi-asserted-by":"publisher","first-page":"7137","DOI":"10.2147\/IJN.S464249","article-title":"Engineering Exosomes for Therapeutic\nApplications:\nDecoding Biogenesis, Content Modification, and Cargo Loading Strategies","volume":"19","author":"Bahadorani","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"2026081907205994400_cit54","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1023\/A:1020261125008","article-title":"Effect of Globotriaosyl\nCeramide Fatty Acid \u03b1-Hydroxylation on the Binding by Verotoxin\n1 and Verotoxin 2","volume":"27","author":"Binnington","year":"2002","journal-title":"Neurochem. Res."},{"issue":"9","key":"2026081907205994400_cit55","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1194\/jlr.M800385-JLR200","article-title":"Fatty Acid-Dependent\nGlobotriaosyl\nCeramide Receptor Function in Detergent Resistant Model Membranes","volume":"50","author":"Mahfoud","year":"2009","journal-title":"J. Lipid Res."},{"issue":"46","key":"2026081907205994400_cit56","doi-asserted-by":"publisher","first-page":"42915","DOI":"10.1074\/jbc.M106015200","article-title":"Kinetic Analysis of\nBinding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface\nPlasmon Resonance","volume":"276","author":"Nakajima","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"2","key":"2026081907205994400_cit57","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00731490","article-title":"Influence of Phospholipid Chain Length on Verotoxin\/Globotriaosyl\nCeramide Binding in Model Membranes: Comparison of a Supported Bilayer\nFilm and Liposomes","volume":"13","author":"Arab","year":"1996","journal-title":"Glycoconj. J."},{"issue":"2","key":"2026081907205994400_cit58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrmicro2279","article-title":"Shiga Toxins\u2500from\nCell Biology to Biomedical\nApplications","volume":"8","author":"Johannes","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"3","key":"2026081907205994400_cit59","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1158\/0008-5472.CAN-17-2880","article-title":"Aptamer-Conjugated\nExtracellular Nanovesicles for Targeted\nDrug Delivery","volume":"78","author":"Wan","year":"2018","journal-title":"Cancer Res."},{"issue":"9","key":"2026081907205994400_cit60","doi-asserted-by":"publisher","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired Exosome-Mimetic\nNanovesicles\nfor Targeted Delivery of Chemotherapeutics to Malignant Tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"key":"2026081907205994400_cit61","doi-asserted-by":"publisher","first-page":"102146","DOI":"10.1016\/j.nano.2019.102146","article-title":"Biomimetic\nNanovesicles Made from iPS Cell-Derived Mesenchymal Stem Cells for\nTargeted Therapy of Triple-Negative Breast Cancer","volume":"24","author":"Zhao","year":"2020","journal-title":"Nanomedicine"},{"issue":"12","key":"2026081907205994400_cit62","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3390\/cells8121509","article-title":"Biofabrication of Cell-Derived Nanovesicles:\nA Potential Alternative to Extracellular Vesicles for Regenerative\nMedicine","volume":"8","author":"Ilahibaks","year":"2019","journal-title":"Cells"},{"key":"2026081907205994400_cit63","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.2147\/IJN.S131786","article-title":"Doxorubicin-Loaded\nCell-Derived Nanovesicles: An Alternative\nTargeted Approach for Anti-Tumor Therapy","volume":"12","author":"Goh","year":"2017","journal-title":"Int.\nJ. Nanomed."},{"issue":"2","key":"2026081907205994400_cit64","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1111\/jcmm.13407","article-title":"Therapeutic\nApplication of Extracellular Vesicles in Kidney Disease: Promises\nand Challenges","volume":"22","author":"Lv","year":"2018","journal-title":"J. Cell. Mol. Med."},{"issue":"2","key":"2026081907205994400_cit65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006266","article-title":"Neutralization of Cholera Toxin with\nNanoparticle Decoys for Treatment of Cholera","volume":"12","author":"Das","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2026081907205994400_cit66","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/glycob\/cwad069","article-title":"Cholera Intoxication\nof Human Enteroids\nReveals Interplay between Decoy and Functional Glycoconjugate Ligands","volume":"33","author":"Singla","year":"2023","journal-title":"Glycobiology"},{"issue":"4","key":"2026081907205994400_cit67","doi-asserted-by":"publisher","first-page":"100104","DOI":"10.1016\/j.engmic.2023.100104","article-title":"The Diverse Landscape\nof AB5-Type Toxins","volume":"3","author":"Brown","year":"2023","journal-title":"Eng. Microbio."},{"issue":"4","key":"2026081907205994400_cit68","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01357-19","article-title":"Breaking the\nConvention: Sialoglycan\nVariants, Coreceptors, and Alternative Receptors for Influenza A Virus\nEntry","volume":"94","author":"Karakus","year":"2020","journal-title":"J. Virol."},{"issue":"30","key":"2026081907205994400_cit69","doi-asserted-by":"publisher","first-page":"596597","DOI":"10.1101\/2024.05.30.596597","article-title":"2\u2019-Fucosyllactose\nInhibits\nHuman Norovirus Replication in Human Intestinal Enteroids","volume":"5","author":"Patil","year":"2024","journal-title":"bioRxiv"},{"key":"2026081907205994400_cit70","doi-asserted-by":"publisher","first-page":"23978","DOI":"10.1038\/srep23978","article-title":"ExtraPEG:\nA Polyethylene Glycol-Based\nMethod for Enrichment of Extracellular Vesicles","volume":"6","author":"Rider","year":"2016","journal-title":"Sci. Rep."},{"key":"2026081907205994400_cit71","doi-asserted-by":"publisher","first-page":"151556","DOI":"10.1016\/j.bbrc.2025.151556","article-title":"B4GALT5-Deficient\nCHO-Lec2 Cells Expressing Human \u03911,4-Galactosyltransferase:\nA Glycoengineered Cell Model for Studying Shiga Toxin Receptors","volume":"754","author":"Miko\u0142ajczyk","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"2026081907205994400_cit72","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1093\/glycob\/cwab041","article-title":"Missing the\nSweet Spot: One of the Two N-Glycans on Human Gb3\/CD77 Synthase Is\nExpendable","volume":"31","author":"Mikolajczyk","year":"2021","journal-title":"Glycobiology"},{"issue":"10","key":"2026081907205994400_cit73","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.3390\/microorganisms9102157","article-title":"The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic\nTarget in Shiga Toxin E. Coli Mediated\nHUS","volume":"9","author":"Feitz","year":"2021","journal-title":"Microorganisms"},{"issue":"8","key":"2026081907205994400_cit74","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1086\/507705","article-title":"Fabry Disease\nin Mice Protects against Lethal Disease Caused by Shiga Toxin-Expressing\nEnterohemorrhagic Escherichia Coli","volume":"194","author":"Cilmi","year":"2006","journal-title":"J. Infect. Dis."},{"issue":"3","key":"2026081907205994400_cit75","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41589-020-0474-4","article-title":"Functional Dissection of the Retrograde Shiga Toxin\nTrafficking Inhibitor Retro-2","volume":"16","author":"Forrester","year":"2020","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"2026081907205994400_cit76","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.201900439","article-title":"Tamoxifen\nBlocks Retrograde Trafficking of Shiga Toxin 1 and 2 and Protects\nagainst Lethal Toxicosis","volume":"2","author":"Selyunin","year":"2019","journal-title":"Life Sci. Alliance"},{"issue":"6","key":"2026081907205994400_cit77","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3390\/toxins13060424","article-title":"Tamoxifen\nDerivatives Alter Retromer-Dependent Endosomal Tubulation and Sorting\nto Block Retrograde Trafficking of Shiga Toxins","volume":"13","author":"Selyunin","year":"2021","journal-title":"Toxins"},{"issue":"2","key":"2026081907205994400_cit78","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cell.2010.01.043","article-title":"Inhibition of Retrograde Transport Protects Mice from\nLethal Ricin Challenge","volume":"141","author":"Stechmann","year":"2010","journal-title":"Cell"},{"issue":"2","key":"2026081907205994400_cit79","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1271\/bbb.65.414","article-title":"Inhibition\nof Vero Cell Cytotoxic Activity in Escherichia Coli O157: H7 Lysates by Globotriaosylceramide, Gb3, from Bovine Milk","volume":"65","author":"Watarai","year":"2001","journal-title":"Biosci., Biotechnol., Biochem."}],"container-title":["Bioconjugate Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.bioconjchem.6c00243","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/37\/8\/1665\/66426807\/acs.bioconjchem.6c00243.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/bcches\/article-pdf\/37\/8\/1665\/66426807\/acs.bioconjchem.6c00243.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T11:30:48Z","timestamp":1787139048000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/bcches\/article\/37\/8\/1665\/5247099\/Surface-Functionalization-of-Small-Extracellular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":79,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,5]]},"published-print":{"date-parts":[[2026,8,19]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.bioconjchem.6c00243","relation":{},"ISSN":["1043-1802","1520-4812"],"issn-type":[{"value":"1043-1802","type":"print"},{"value":"1520-4812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}